Skip to content
Review Open access

Targeting Key Mechanisms of Nutraceuticals in Chronic Pain: A Narrative Review.

Oct 2026 · Nutrients · Vol 18 21 · 0 citations
Medicine

TL;DR

A mechanism-based overview of nutraceuticals in CP across five interconnected domains is provided: neuroinflammation, oxidative stress and mitochondrial dysfunction, central sensitization, peripheral sensitization, peripheral sensitization, and descending inhibitory modulation.

Abstract

Chronic pain (CP) is a major cause of disability worldwide and reflects interactions among multiple pathophysiological mechanisms. Despite the availability of pharmacological therapies, many patients continue to experience inadequate pain control, supporting interest in complementary approaches. Nutraceuticals have been investigated as potential adjuncts because several compounds modulate biological pathways implicated in pain persistence. This narrative review provides a mechanism-based overview of nutraceuticals in CP across five interconnected domains: neuroinflammation, oxidative stress and mitochondrial dysfunction, central sensitization, peripheral sensitization, and descending inhibitory modulation. Literature was identified in PubMed/MEDLINE and the Cochrane Library, with the final update completed on 8 October 2026; preclinical mechanisms and clinical efficacy were evaluated separately. Earlier short-term trials of alpha-lipoic acid suggested symptomatic improvement in diabetic peripheral neuropathy, whereas a 2024 Cochrane review found little or no benefit after six months. Evidence syntheses suggest possible analgesic effects of palmitoylethanolamide in mixed chronic pain populations and of curcuminoids in knee osteoarthritis. Clinical studies of omega-3 fatty acids also suggest a possible reduction in pain intensity, although substantial heterogeneity across conditions, formulations, and study designs limits interpretation. Across compounds, mechanistic plausibility generally exceeds evidence of clinical efficacy and direct target engagement in humans. Future studies should prioritize standardized formulations, clinically relevant outcomes, adequate follow-up, safety assessment, and mechanistic biomarkers within phenotype-informed pain management.

Read PDF

Similar papers

Review Nov 2026

Emerging biochemical targets in chronic pain: bridging molecular mechanisms and public health policy in the Indian context.

INTRODUCTION India confronts a chronic-pain paradox widespread under-treatment of pain coexisting with intense restriction of opioid prescribing. India's prevailing opioid-constrained pain-management model, constrained by narcotic legislation, institutional caution, and cultural stigma, is biochemically and clinically...

Aniruddha Sen, Suresh K. Srinivasan, P. Mohanraj et al. · 0 citations
Review Open access Oct 2026

Neuropathic Pain Comorbid Cognitive Impairment and Vitamin D: A Narrative Review From Mechanisms to Clinical Management

ABSTRACT Neuropathic pain (NP) is not merely simple persistent pain but a complex pathological condition mediated by dysregulation across multiple systems, including the neuro‐immune‐endocrine axis. As a high‐intensity endogenous stressor, persistent pain signals can deplete cognitive resources and trigger neuroinflamm...

Nan Zhao, Yang Yang, Wan-Qiu Yu et al. · 0 citations
Review Open access Sep 2026

Neuroplastic mechanisms of chronic pain: Implications and future directions

Chronic pain is now increasingly viewed as aberrant neuroplasticity rather than a protracted expression of peripheral nociception. This review integrates current knowledge through the lens of a peripheral-to-central paradigm, whereby peripheral sensory sensitization contributes to pain initiation, spinal excitation–inh...

Kai-Kai Wang, Yan-Hui He, Jin-Hai Liu et al. · 0 citations
Review Open access Sep 2026

POTENTIAL USE OF GLP-1 RECEPTOR AGONISTS IN THE MANAGEMENT OF CHRONIC PAIN SYNDROMES: ANTI-INFLAMMATORY AND NEUROPROTECTIVE PERSPECTIVES

Chronic pain syndromes remain a major clinical and public health challenge because of their multifactorial pathophysiology, frequent refractoriness to standard treatment, and marked effects on quality of life, disability, sleep, psychological well-being, and work capacity. Glucagon-like peptide-1 receptor agonists (GLP...

Dominika Krupnik, W. Skowron, Mateusz Skowron et al. · 0 citations
Review Open access Oct 2026

Balneotherapy in knee osteoarthritis: a review of therapeutic efficacy and inflammatory cytokine regulation

Knee osteoarthritis (KOA) is a common degenerative joint disease with an inflammatory component. Balneotherapy has been used for KOA, but its clinical efficacy and mechanisms remain uncertain. This narrative review summarizes clinical evidence and proposes a hypothesis-generating mechanistic framework. PubMed and CNKI...

Xiang-Feng Lai, Ling-Zhong-Hu-Ti-Wen-Ji-Zhi-Ji-Nian-Gai-De-Yan-Jie Ji, Yu-Zhe Zou et al. · 0 citations
Review Open access Sep 2026

Emerging pharmacological strategies for neuropathic pain: Mechanism-based targeting and precision medicine

Neuropathic pain (NP) is a type of chronic pain syndrome due to structural or functional alterations in the somatosensory nervous system after injury, including long-lasting painful sensations and allodynia and hyperalgesia. Due to its intricate pathophysiology and significant interindividual variation in therapeutic r...

Rui Zhao · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.